Novel findings from a metabolomics study of left ventricular diastolic function: The Bogalusa Heart Study
Journal of the American Heart Association Feb 05, 2020
Razavi AC, Bazzano LA, He J, et al. - Given the value of diastolic dysfunction as one important causal factor for heart failure with preserved ejection fraction, researchers here sought for the metabolic signature associated with this subclinical phenotype. Using ultra-high-performance liquid chromatography–tandem mass spectroscopy, untargeted metabolomic analysis of fasting serum samples in 1,050 white and black participants of the BHS (Bogalusa Heart Study) was conducted. Outcomes revealed a robust association of eight metabolites with left ventricular diastolic function in the overall population; consistent associations were noted in white and black study participants. The natural log of the ratio of peak early filling velocity to mitral annular velocity was noted to be significantly correlated with the following: N-formylmethionine; 1-methylhistidine; formiminoglutamate; N2, N5-diacetylornithine; N-trimethyl 5-aminovalerate; 5-methylthioadenosine; and methionine sulfoxide. A significant association of butyrylcarnitine with isovolumic relaxation time was observed. These findings suggest the possible implications of serum metabolome, and its underlying biological pathways, in heart failure with preserved ejection fraction pathogenesis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries